Dupont Capital Management Corp boosted its position in Varian Medical Systems, Inc. (NYSE:VAR) by 41.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 8,620 shares of the medical equipment provider’s stock after buying an additional 2,517 shares during the quarter. Dupont Capital Management Corp’s holdings in Varian Medical Systems were worth $958,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in VAR. Thrivent Financial For Lutherans raised its stake in Varian Medical Systems by 1.5% in the 2nd quarter. Thrivent Financial For Lutherans now owns 3,480 shares of the medical equipment provider’s stock valued at $359,000 after acquiring an additional 50 shares during the period. Dimensional Fund Advisors LP raised its stake in Varian Medical Systems by 0.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 313,073 shares of the medical equipment provider’s stock valued at $32,305,000 after acquiring an additional 2,764 shares during the period. BlueCrest Capital Management Ltd raised its stake in Varian Medical Systems by 78.0% in the 2nd quarter. BlueCrest Capital Management Ltd now owns 21,264 shares of the medical equipment provider’s stock valued at $2,194,000 after acquiring an additional 9,319 shares during the period. Raymond James Financial Services Advisors Inc. grew its holdings in Varian Medical Systems by 4.5% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 3,250 shares of the medical equipment provider’s stock valued at $335,000 after buying an additional 141 shares in the last quarter. Finally, Bank of Nova Scotia grew its holdings in Varian Medical Systems by 8.2% during the 2nd quarter. Bank of Nova Scotia now owns 20,827 shares of the medical equipment provider’s stock valued at $2,149,000 after buying an additional 1,585 shares in the last quarter. Institutional investors and hedge funds own 99.19% of the company’s stock.

In other news, EVP Kolleen T. Kennedy sold 2,021 shares of the business’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $107.36, for a total transaction of $216,974.56. Following the completion of the transaction, the executive vice president now owns 27,595 shares of the company’s stock, valued at $2,962,599.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy E. Guertin sold 10,000 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $111.46, for a total value of $1,114,600.00. Following the transaction, the director now directly owns 2,161 shares of the company’s stock, valued at approximately $240,865.06. The disclosure for this sale can be found here. Insiders have sold 139,842 shares of company stock valued at $15,923,110 in the last three months. 0.78% of the stock is owned by insiders.

Varian Medical Systems, Inc. (NYSE VAR) opened at $116.92 on Thursday. Varian Medical Systems, Inc. has a twelve month low of $77.73 and a twelve month high of $130.29. The company has a market capitalization of $10,959.22, a PE ratio of 93.54, a PEG ratio of 3.47 and a beta of 0.81.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The company had revenue of $678.50 million during the quarter, compared to analyst estimates of $633.96 million. During the same quarter in the previous year, the firm earned $1.09 earnings per share. Varian Medical Systems’s revenue was up 12.8% on a year-over-year basis. analysts anticipate that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current fiscal year.

A number of research firms have weighed in on VAR. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a report on Sunday, January 28th. JPMorgan Chase & Co. lifted their target price on Varian Medical Systems from $88.00 to $105.00 and gave the company a “neutral” rating in a report on Thursday, January 25th. Citigroup lifted their target price on Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a report on Thursday, January 25th. Royal Bank of Canada lifted their target price on Varian Medical Systems to $115.00 and gave the company a “sector perform” rating in a report on Thursday, January 25th. Finally, Zacks Investment Research raised Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Monday, January 29th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $106.40.

COPYRIGHT VIOLATION WARNING: This report was originally reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/02/08/dupont-capital-management-corp-increases-position-in-varian-medical-systems-inc-var.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.